Lotus Pharmaceutical Co., Ltd. (TPE: 1795)
Taiwan
· Delayed Price · Currency is TWD
253.00
-2.50 (-0.98%)
Oct 11, 2024, 1:30 PM CST
Lotus Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 2,856 | 1,771 | 1,983 | 1,605 | 1,489 | 1,277 | Upgrade
|
Cash & Short-Term Investments | 2,856 | 1,771 | 1,983 | 1,605 | 1,489 | 1,277 | Upgrade
|
Cash Growth | 62.12% | -10.71% | 23.54% | 7.82% | 16.61% | 24.79% | Upgrade
|
Accounts Receivable | 6,815 | 6,384 | 4,651 | 3,266 | 2,747 | 2,267 | Upgrade
|
Other Receivables | 260.39 | 233.13 | 276.24 | 141.56 | 53.19 | 149.97 | Upgrade
|
Receivables | 7,075 | 6,617 | 4,927 | 3,407 | 2,801 | 2,417 | Upgrade
|
Inventory | 3,811 | 3,775 | 3,330 | 3,073 | 2,208 | 1,343 | Upgrade
|
Other Current Assets | 456.78 | 489.37 | 420.4 | 247.24 | 284.61 | 684.14 | Upgrade
|
Total Current Assets | 14,200 | 12,653 | 10,661 | 8,333 | 6,783 | 5,721 | Upgrade
|
Property, Plant & Equipment | 3,639 | 3,511 | 3,148 | 2,642 | 2,305 | 2,049 | Upgrade
|
Long-Term Investments | 3,070 | 3,048 | 2,158 | 301.73 | 412.85 | 458.06 | Upgrade
|
Goodwill | 5,591 | 5,670 | 5,668 | 5,586 | 5,896 | 5,910 | Upgrade
|
Other Intangible Assets | 5,158 | 5,487 | 5,910 | 2,971 | 3,177 | 2,102 | Upgrade
|
Long-Term Accounts Receivable | 169.05 | 152.6 | - | - | - | - | Upgrade
|
Long-Term Deferred Tax Assets | 420.19 | 411.69 | 390.12 | 310.82 | 364.61 | 378.65 | Upgrade
|
Long-Term Deferred Charges | 2,228 | 1,878 | 1,406 | 891.98 | 654.1 | 808.96 | Upgrade
|
Other Long-Term Assets | 163.42 | 180.28 | 185.33 | 185.35 | 161.12 | 767.4 | Upgrade
|
Total Assets | 34,638 | 32,992 | 29,526 | 21,222 | 19,753 | 18,195 | Upgrade
|
Accounts Payable | 789.9 | 670.8 | 1,403 | 747.55 | 1,732 | 934.67 | Upgrade
|
Accrued Expenses | 1.01 | 3.87 | 3.57 | 0.93 | 2.46 | 108.47 | Upgrade
|
Short-Term Debt | 293.53 | 510 | 155.92 | 1,377 | 410 | 460 | Upgrade
|
Current Portion of Long-Term Debt | 2,102 | 1,303 | 59.95 | 794.9 | 1,359 | 579.08 | Upgrade
|
Current Portion of Leases | 90.22 | 70.24 | 58.99 | 62.47 | 40.43 | 58.93 | Upgrade
|
Current Income Taxes Payable | 679.72 | 436.56 | 731.15 | 280.16 | 226.62 | 60.29 | Upgrade
|
Current Unearned Revenue | 180.85 | 132.85 | 183.08 | 132.01 | 132.1 | 65.05 | Upgrade
|
Other Current Liabilities | 2,445 | 1,397 | 3,297 | 931.26 | 980.66 | 834.03 | Upgrade
|
Total Current Liabilities | 6,582 | 4,524 | 5,893 | 4,326 | 4,883 | 3,101 | Upgrade
|
Long-Term Debt | 7,977 | 9,519 | 8,596 | 4,667 | 4,948 | 6,134 | Upgrade
|
Long-Term Leases | 205.13 | 182.2 | 46.82 | 43.41 | 76.58 | 115.9 | Upgrade
|
Long-Term Unearned Revenue | 34.29 | 45.33 | 65.92 | 85.96 | 111.78 | 104.04 | Upgrade
|
Long-Term Deferred Tax Liabilities | 709.1 | 721.2 | 448.4 | 304.15 | 144.69 | 172.25 | Upgrade
|
Other Long-Term Liabilities | 128.67 | 162.29 | 235.84 | 224.03 | 257.46 | 280.92 | Upgrade
|
Total Liabilities | 16,158 | 15,658 | 15,658 | 10,153 | 11,008 | 10,476 | Upgrade
|
Common Stock | 2,655 | 2,650 | 2,626 | 2,628 | 2,454 | 2,431 | Upgrade
|
Additional Paid-In Capital | 7,293 | 7,131 | 7,534 | 8,039 | 6,799 | 6,588 | Upgrade
|
Retained Earnings | 10,036 | 8,900 | 4,823 | 1,701 | 353.66 | -652.94 | Upgrade
|
Treasury Stock | -48.69 | -51.1 | -57.35 | -57.75 | - | - | Upgrade
|
Comprensive Income & Other | -1,455 | -1,295 | -1,058 | -1,241 | -860.97 | -624.22 | Upgrade
|
Total Common Equity | 18,480 | 17,334 | 13,868 | 11,069 | 8,745 | 7,742 | Upgrade
|
Minority Interest | - | - | - | - | - | -23.51 | Upgrade
|
Shareholders' Equity | 18,480 | 17,334 | 13,868 | 11,069 | 8,745 | 7,719 | Upgrade
|
Total Liabilities & Equity | 34,638 | 32,992 | 29,526 | 21,222 | 19,753 | 18,195 | Upgrade
|
Total Debt | 10,668 | 11,585 | 8,918 | 6,944 | 6,834 | 7,348 | Upgrade
|
Net Cash (Debt) | -7,812 | -9,814 | -6,935 | -5,339 | -5,345 | -6,072 | Upgrade
|
Net Cash Per Share | -29.72 | -37.45 | -26.50 | -20.80 | -21.95 | -25.10 | Upgrade
|
Filing Date Shares Outstanding | 265.05 | 264.47 | 262.04 | 262.25 | 245.35 | 243.11 | Upgrade
|
Total Common Shares Outstanding | 265.05 | 264.47 | 262.04 | 262.25 | 245.35 | 243.11 | Upgrade
|
Working Capital | 7,617 | 8,129 | 4,768 | 4,007 | 1,900 | 2,621 | Upgrade
|
Book Value Per Share | 69.72 | 65.54 | 52.92 | 42.21 | 35.64 | 31.85 | Upgrade
|
Tangible Book Value | 7,731 | 6,177 | 2,291 | 2,512 | -327.16 | -269.55 | Upgrade
|
Tangible Book Value Per Share | 29.17 | 23.36 | 8.74 | 9.58 | -1.33 | -1.11 | Upgrade
|
Land | 612.86 | 622.55 | 622.31 | 615.49 | 654.22 | 656.01 | Upgrade
|
Buildings | 2,083 | 1,888 | 1,384 | 1,313 | 1,012 | 988.14 | Upgrade
|
Machinery | 1,847 | 1,826 | 1,547 | 1,408 | 1,324 | 1,238 | Upgrade
|
Construction In Progress | 582.26 | 639.41 | 1,077 | 675.22 | 608.86 | 275.6 | Upgrade
|
Leasehold Improvements | 85.27 | 71.01 | 87.87 | 78.26 | 85.33 | 85.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.